Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

被引：0
作者：
Buisson, A. [1 ]
Nachury, M. [2 ]
Fumery, M. [3 ]
Guilmoteau, T. [1 ]
Leclerc, E. [1 ]
Altwegg, R. [4 ]
Serrero, M. [5 ]
Mathieu, N. [6 ]
Treton, X. [7 ]
Vuitton, L. [8 ]
Pereira, B. [9 ]
Amiot, A. [10 ]
Bouguen, G. [11 ]
机构：
[1] Univ Hosp Estaing, Dept Gastroenterol, IBD Unit, Clermont Ferrand, France
[2] CHRU Lille, IBD Unit, Lille, France
[3] CHU Amiens, IBD Unit, Amiens, France
[4] CHU Montpellier, IBD Unit, Montpellier, France
[5] AP HM, IBD Unit, Marseille, France
[6] CHU Grenoble, IBD Unit, Grenoble, France
[7] AP HP Beaujon Hosp, IBD Unit, Paris, France
[8] CHU Besancon, IBD Unit, Besancon, France
[9] Univ Hosp Estaing, DRCI Biostat Unit, Clermont Ferrand, France
[10] AP HP Creteil Hosp, IBD Unit, Paris, France
[11] CHU Rennes, IBD Unit, Rennes, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP76
引用
收藏
页码：I120 / I120
页数：1
相关论文
共 50 条
  • [41] Real-world clinical and endoscopic outcomes after one year tofacitinib treatment in ulcerative colitis
    Straatmijer, Tessa
    van Gennep, Sara
    Duijvestein, Marjolijn
    Ponsioen, Cyriel I. J.
    Gecse, Krisztina B.
    D'Haens, Geert R.
    Lowenberg, Mark
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (10) : 1288 - 1297
  • [42] Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis
    Biron, I. Avni
    Shitrit, A. Bar-Gil
    Koslowsky, B.
    Kopylov, U.
    Levartovsky, A.
    Weisshof, R.
    Aviv-Cohen, N.
    Maharshak, N.
    Hovel, D.
    Naftali, T.
    Goren, I.
    Snir, I.
    Ollech, J.
    Banai, H.
    Lena, B.
    Dotan, I.
    Yanai, H.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S498 - S499
  • [43] Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study
    Buisson, A.
    Treton, X.
    Nachury, M.
    Uzzan, M.
    Bouguen, G.
    Hamadidi, A. Banana
    Amiot, A.
    Serrero, M.
    Fumery, M.
    Caillo, L.
    Hupe, M.
    Pereira, B.
    Altwegg, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1212 - i1212
  • [44] Real-world evidence comparison of the effectiveness of ustekinumab with anti-TNF or vedolizumab in ulcerative colitis: 1-year maintenance therapy results from the prospective, observational RUN-UC study
    Bokemeyer, B.
    Plachta-Danielzik, S.
    Howaldt, S.
    Mohl, W.
    Efken, P.
    Ehehalt, R.
    Kahl, M.
    Krause, T.
    Trentmann, L.
    Luegering, A.
    Schnoy, E.
    Jochum, C.
    Salmon, S. Fajardo
    Hartmann, P.
    Gilman, E.
    Schreiber, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1470 - I1471
  • [45] Real-world evidence comparison of the effectiveness of ustekinumab with anti-TNF or vedolizumab in ulcerative colitis: 2-year maintenance therapy results from the prospective, observational RUN-UC study
    Bokemeyer, B.
    Plachta-Danielzik, S.
    Howaldt, S.
    Mohl, W.
    Efken, P.
    Ehehalt, R.
    Kahl, M.
    Krause, T.
    Trentmann, L.
    Luegering, A.
    Schnoy, E.
    Jochum, C.
    Salmon, S. Fajardo
    Hartmann, P.
    Gilman, E.
    Schreiber, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2131 - i2132
  • [46] Comparison of clinical and endoscopic efficacy between vedolizumab and infliximab in bio-naïve patients with ulcerative colitis: a multicenter, real-world study
    Huang, Zhaopeng
    Tang, Jian
    Wu, Ruibin
    Long, Shunhua
    Chen, Wenke
    Lu, Tingna
    Xia, Qiuyue
    Wu, Yanhui
    Yang, Hongsheng
    Yang, Qingfan
    Huang, Zicheng
    Guo, Qin
    Li, Miao
    Gao, Xiang
    Chao, Kang
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [47] Effect of Tofacitinib on One-Year Colectomy Risk in Anti-TNF Refractory Ulcerative Colitis: A Prospective Multicenter Italian Study
    Gabrielli, Anna Maria Carvalhas
    Ferretti, Francesca
    Monico, Camilla Maria
    Tombetti, Enrico
    Maconi, Giovanni
    Romeo, Samanta
    Sed, Nicole Piazza O.
    Caprioli, Flavio
    Mazzola, Anna Maria
    Alicante, Saverio
    Berte, Roberto
    Lolli, Elisabetta
    Scribano, Maria Lia
    Buscarini, Elisabetta
    Ricci, Chiara
    Carmagnola, Stefania
    Ardizzone, Sandro
    Cannatelli, Rosanna
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (05) : 1785 - 1792
  • [48] Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
    Straatmijer, Tessa
    Biemans, Vince B. C.
    Visschedijk, Marijn
    Hoentjen, Frank
    de Vries, Annemarie
    van Bodegraven, Adriaan A.
    Bodelier, Alexander
    de Boer, Nanne K. H.
    Dijkstra, Gerard
    Festen, Noortje
    Horjus, Carmen
    Jansen, Jeroen M.
    Jharap, Bindia
    Mares, Wout
    van Schaik, Fiona D. M.
    Ponsioen, Cyriel
    Romkens, Tessa
    Srivastava, Nidhi
    van der Voorn, Michael M. P. J. A.
    West, Rachel
    van der Woude, Janneke
    Wolvers, Marije D. J.
    Pierik, Marieke
    van der Meulen-de Jong, Andrea E.
    Duijvestein, Marjolijn
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (01) : 182 - +
  • [49] Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study
    Meyer, Antoine
    Fumery, Mathurin
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Altwegg, Romain
    Bouhnik, Yoram
    Serrero, Melanie
    Laharie, David
    Roblin, Xavier
    Nachury, Maria
    Abitbol, Vered
    Cadiot, Guillaume
    Nancey, Stephane
    Allez, Matthieu
    Gilletta, Cyrielle
    Vuitton, Lucine
    Savoye, Guillaume
    Nahon, Stephane
    Bourrier, Anne
    Buisson, Anthony
    Bouguen, Guillaume
    Bourreille, Arnaud
    Viennot, Stephanie
    Carbonnel, Franck
    Amiot, Aurelien
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 1454 - 1462
  • [50] Comparison of the efficacy of a second intravenous or subcutaneous anti-TNF in the treatment of ulcerative colitis: Real-world data from the ENEIDA registry
    Torres-Rodriguez, P.
    Canete, F.
    Calafat, M.
    Sanchez-Aldehuelo, R.
    Rivero, M.
    Iborra, M.
    Gonzalez-Vivo, M.
    Vera, I.
    de Castro, L.
    Bujanda, L.
    Barreiro-de Acosta, M.
    Calvet, X.
    Benitez, J. M.
    Llorente, M.
    Suris, G.
    Arias-Garcia, L.
    David, M.
    Castano-Garcia, A.
    Garcia-Alonso, F. J.
    Rufo, L.
    Ferrer, J. A.
    Camo, P.
    Gisbert, J. P.
    Huguet, J. M.
    Pajares, R.
    Morales, V.
    Llao, J.
    Rodriguez, A.
    Rodriguez, C.
    Navarro, M.
    Gomollon, F.
    Carrillo-Palau, M.
    Sese, E.
    Almela, P.
    Ramirez de la Piscina, P.
    Rodriguez-Lago, I.
    Papo, M.
    Vela, M.
    Manosa, M.
    Domenech, E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S463 - S464
12345